[Business Wire] – AstraZeneca and Bristol-Myers Squibb Company today announced that the companies’ U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association’s Pathway to Stop Diabetes program.
Read more on this.
Bristol-Myers Squibb Company (NYSE:BMY) ~ AstraZeneca and Bristol-Myers Squibb Diabetes Alliance Provides $5 Million Grant for American Diabetes Association’s Pathway to Stop Diabetes Research Initiative
January 16, 2014 at 08:30 AM EST
[Business Wire] – AstraZeneca and Bristol-Myers Squibb Company today announced that the companies’ U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association’s Pathway to Stop Diabetes program. Read more . . . → Read More: Bristol-Myers Squibb Company (NYSE:BMY) ~ AstraZeneca and Bristol-Myers Squibb Diabetes Alliance Provides $5 Million Grant for American Diabetes Association’s Pathway to Stop Diabetes Research Initiative
